Connect your AI

Corvel CRVL Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

BrightSpring Health Services, Inc.BTSG

-$573K-267%

NovantaNOVT

$248K-94.3%

CognizantCTSH

$0-100%

IQVIAIQV

-$18M-1,700%

McKessonMCK

$102M+3,300%

Global PaymentsGPN

——

Other financials

Income statement

Revenue$248.5M+7.4%

Gross profit$63.0M+8.3%

Net income$31.0M+17.4%

EPS (diluted)$0.61+19.6%

Balance sheet

Cash & equivalents$233.1M+36.6%

Total debt$28.1M+0.1%

Total equity$394.2M+22.4%

Total assets$643.0M+17.8%

Cash flow

Operating cash flow$29.5M+28.6%

CapEx$9.2M+5.9%

Free cash flow$20.3M+42.3%

Valuation

Market cap$3.03B-51.4%

Enterprise value$2.82B-53.8%

P/E27.4×-38.0×

P/S3.2×-3.8×

Profitability

Gross margin24.3%+0.9pp

Net margin11.5%+0.9pp

FCF margin11.5%+1.3pp

Returns & leverage

Return on equity30.8%-2.6pp

Debt / equity0.1×0.0×

Current ratio2×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.

The official record: Corvel’s 10-K, filed May 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Corvel's gain/loss on asset sales?: Corvel (CRVL) reported gain/loss on asset sales of -$698K in Q1 2026.
How has Corvel's gain/loss on asset sales changed year-over-year?: Corvel's gain/loss on asset sales decreased by 110.9% year-over-year, from -$331K to -$698K.
What is the long-term trend for Corvel's gain/loss on asset sales?: Over 4 years (2022 to 2026), Corvel's gain/loss on asset sales has grown at a 55.7% compound annual growth rate (CAGR), from -$122K to -$717K.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.